Keywords: sales, main, products, boosts, sanofi-aventis, profit, 89b
Sales of main products boosts Sanofi-Aventis' profit 1.9% to 1.89B euros
Article | 10 November 2008
Sanofi-Aventis' third-quarter 2008 profit, adjusted for merger-related costs, rose 1.9% year-on-year to 1.89 billion euros ($2.35 billion), thanks to higher sales of its top ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US Supreme Court says patent settlement can "sometimes" be illegal
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
